Importantly, upregulation of certain anti-apoptotic BCL-2 family members, such as BCL-2, B cell lymphoma-extra-large (BCL-XL), and myeloid cell leukemia (MCL-1), are also known to support development and survival of cancerous cells as well as evasion from cancer therapy6. The gene discussed is BCL2; the disease is cancer.